The purpose of this study is to isolate genotype-specific DBP/Gc from homozygous human volunteers and use these purified proteins to cross-validate existing or novel assays for this serum protein and to evaluate the binding characteristics of these variants of DBP/Gc for different vitamin D metabolites.
Study Type
OBSERVATIONAL
Enrollment
24
Sampling of 100-150 ml of blood
UZ Leuven
Leuven, Belgium
Vitamin D binding protein binding characteristics (affinity constant)
In vitro characterization
Time frame: single blood draw at time of consultation, an expected average 4 years after curative treatment for breast cancer
Correlation coefficient (r) of different DBP assays
In vitro characterization
Time frame: single blood draw at time of consultation, an expected average 4 years after curative treatment for breast cancer
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.